Gdp to be negative this the First Quarter of 2021. It is friday before a holiday week 59 minutes left in the session down a quarter of a percent on the s p 500. No gobbledy gook coming up for the next two hours here either. Coming up on this show, instead we are going to dive into the latest on the coronavirus and pfizers push to get emergency use authorization for its vaccine with the fda commissioner and pfizer board member dr. Scott gottlieb. Plus, new york city shutting st. Louis down the head of the Teachers Union in new york will be here to weigh in. Lets check on futures mike santoli tracking the margaret as always meg tirrell with the latest on pfizers vaccine and bertha comes has the latest on what President Trump just announced. Mike santoli, lets start with you. Not disturbed so far by the news last night about the treasury pulling the funds from the fed. If you look at the pattern here, it is about a flat week as well. Trading just below the highs we hit on monday. Before t
WW International, Inc. (NASDAQ:WW) Q2 2023 Earnings Call Transcript August 3, 2023 WW International, Inc. beats earnings expectations. Reported EPS is $0.65, expectations were $0.08. Operator: Good afternoon and welcome to the WW International Second Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note this event is being […]
Published: Feb 26, 2021
NEW YORK, Feb. 26, 2021 /PRNewswire/ WW International, Inc. (NASDAQ: WW), a human-centric technology company powered by the world s leading commercial weight management program, announced today that Adam Kaufman, PhD has joined the company as Senior Vice President, Healthcare and Diabetes. In this role, Adam will manage WW Health Solutions, the existing business, and lead the development of a dedicated offering specifically designed for people with diabetes. He will sit on the senior leadership team and report to Nick Hotchkin, Chief Operating Officer. WW Health Solutions continues to be a key strategic growth lever for our business and we will now also focus on the broader healthcare market as well as diabetes as a core WW consumer offering, said Nick Hotchkin, WW Chief Operating Officer. We are thrilled to have Adam join the team. In addition to his deep expertise in diabetes, he has unique experience in applying technology to improvements i